LncRNA-MUF, also known as mesenchymal stem cell upregulated factor (lncRNA-MUF), promotes hepatocellular carcinoma by binding to ANXA2 to activate WNT/β-catenin signaling-mediated EMT (26). The gene discussed is ANXA2; the disease is hepatocellular carcinoma.